Looking for a mood lift? Buck CEO Eric Verdin's new blog shares the overwhelming sense of optimism in the aging research field and outlines how some research is moving toward use in the clinic.
@TheDrWiley discusses cexciting new research he led on cellular #senescence while at @BuckInstitute hhttps://www.buckinstitute.org/news/the-first-non-invasive-biomarker-to-track-and-verify-efficacy-of-senolytic-drugs/
Hot off the Buck blog press: With COVID vaccines being widely available to the public, many are wondering how they work. Our @DominicanCAnews students explain different types and how scientific community was able to develop safe vaccines so quickly. https://www.buckinstitute.org/blog/a-shot-towards-ending-a-pandemic-vaccines-explained/
Quick! You have 9 minutes to get inspired about science and learn why #Celegans is an excellent model organism, especially for #aging and disease. Don't worry, @BBC Witness History and our own Gordon Lithgow gotchu. https://www.bbc.co.uk/sounds/play/w3ct1x54
Buck Job Alert! Principal Grants & Contracts Analyst w/ research admin experience working w/ faculty in academic or research setting. Ideal candidate has experience w/ various funding types and human subjects research protections and IRB regulations. https://app.jobvite.com/j?cj=o7Lcffw3&s=Social
New from @KECKSchool_USC: rapid biological aging of #neuralstemcells--they become quiescent and decline as mice reach middle age. Inhibiting the #Abl1 gene in mice led to proliferation of these "long-term" NSCs. https://www.eurekalert.org/pub_releases/2021-04/ksom-usc041221.php
